Navigation Links
Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results
Date:3/7/2011

justed net income/(loss) per diluted share.  We believe these non-GAAP financial measures are helpful in understanding our past financial performance and our potential future results.  They are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read in conjunction with our consolidated financial statements prepared in accordance with GAAP.  Our management regularly uses these supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and make operating decisions.  Compensation of our executives is based in part on the performance of our business based on these non-GAAP measures.  In addition, we believe that the use of these non-GAAP measures enhances the ability of investors to compare our results from period to period.  Investors should note that adjusted net income/(loss) and adjusted net income/(loss) per diluted share, as used by Jazz Pharmaceuticals, may be calculated differently from, and therefore may not be directly comparable to, similarly titled measures used by our competitors and other companies.  Adjusted net income/(loss) and adjusted net income/(loss) per diluted share exclude from the comparable GAAP measures:  revenue related to upfront and milestone payments, the impact of a change in the timing of when Luvox CR revenue is recognized, a loss on extinguishment of debt, amortization of intangible assets, stock-based compensation, and non-cash interest expense associated with a debt discount and debt issuance costs.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995This press release contains forward-looking statements, including, but not limited to, statements related to Jazz Pharmaceuticals' financial performance, profitability and growth potential and future financial performance, including 2011 financial guidance, and statements relating to future product sales and product c
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 2015  Boston Children,s Hospital physicians report the ... of their anatomy before undergoing high-risk brain procedures. ... in the brain,s blood vessels) that posed special ... the Journal of Neurosurgery: Pediatrics , the ... synthetic resins to create custom, high-fidelity models of ...
(Date:7/31/2015)... July 31, 2015 Egalet Corporation (Nasdaq: ... pharmaceutical company focused on developing, manufacturing and marketing ... its previously announced underwritten public offering of 7,666,667 ... offering price of $11.25 per share. The shares ... shares issued upon the exercise in full by ...
(Date:7/31/2015)... According to a new market research report ... Dual-Energy X-ray Absorptiometry (DEXA), Skinfold Calipers, Air Displacement Plethysmography ... to 2019", published by MarketsandMarkets, the global Body Composition ... is estimated to grow to $1,425.7 Million by 2019, ... 2019. Browse 41 market data Tables ...
Breaking Medicine Technology:3D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4
... Technologies, a global leader in scientific asset management, biomaterial ... in the AMDeC Vendor Partnership Program. This program provides ... products and services crucial to medical research and will ... BioStorage Technologies. AMDeC is a consortium ...
... 17, 2011 Ingenious Med, the leading platform for ... is now available on the App Store for iPhone, ... as part of the company,s presence at the Hospital ... enables Ingenious Med,s 9,000 users to access the charge ...
Cached Medicine Technology:BioStorage Technologies Partners with AMDeC, LLC to Provide Tissue Storage and Cold Chain Logistics Services to Academic Medical Research Institutions 2BioStorage Technologies Partners with AMDeC, LLC to Provide Tissue Storage and Cold Chain Logistics Services to Academic Medical Research Institutions 3HIMSS11: Ingenious Med Launches Billing and Data Capture App for iPhone, iPod touch and iPad 2
(Date:8/2/2015)... ... August 02, 2015 , ... Molecular biologists in New ... indicator for mesothelioma. Surviving Mesothelioma has just posted an article on the new research. ... New South Wales tested for Ki67 expression in tissue samples from 42 patients with ...
(Date:8/1/2015)... ... August 01, 2015 , ... The condition where veins are ... and women often causing pain and discomfort. Those who spend a lot of time ... Northeast Houston Vein Center is doing what it can to create awareness and provide ...
(Date:8/1/2015)... ... August 01, 2015 , ... On Tuesday, July 28th, Symantec released a ... to have been behind the attack on Anthem Inc. which resulted in one of ... watering hole attacks and spear phishing campaigns. , For Joe Caruso, founder ...
(Date:7/31/2015)... ... July 31, 2015 , ... That’s right, the ... the STASH awards? The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, ... as tried-and-true products that have stood the test of time. These include lighting ...
(Date:7/31/2015)... IL (PRWEB) , ... July 31, 2015 , ... Ticket ... which is currently going on in Chicago at Grant Park. The festival will ... corner of North America to Chicago for the annual Lollapalooza. This unique and ...
Breaking Medicine News(10 mins):Health News:Scientists Link Protein Marker with Mesothelioma Prognosis in New Study, According to Surviving Mesothelioma 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2
... 30 ATS Medical, Inc.,(Nasdaq: ATSI ), ... services, today announced it has received U.S. Food,and ... Aortic,Bioprosthesis., (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ), This ... Million U.S.,tissue valve market. Based on the precept ...
... AIRM ) announces the following Webcast:, What: ... November 6, 2008 @ 4:15 p.m. ET, Where: ... the Internet -- Simply log on to the web at the ... Contact: Christine Clarke of Air Methods Corporation, +1-303-792-7579., If ...
... October is National Physical Therapy,month and to ... Michigan residents to "Become a Physical Therapist or ... face uncertain economic times, the,physical therapy profession continues ... Director Aaron Bailey, PT, says there,is an urgent ...
... Successfully Work,Together to Improve Health and Lower Costs, ... health care system,and escalating costs associated with chronic ... in this year,s presidential campaigns, an,innovative employer-based program ... reducing costs for people with diabetes., To ...
... with Diabetes Will Meet Nick Jonas in Los Angeles ... TARRYTOWN, N.Y., Oct. 30 To kick off Diabetes ... diabetes have,won the opportunity to meet teen pop sensation ... "Walk In Nick,s Shoes" (W.I.N.S.),sweepstakes. These Grand Prize winners ...
... SMA ), a leading independent provider of products ... announced today that,it will release third quarter financial results ... opens on Wednesday, November 12, 2008.,Symmetry Medical will host ... November 12, 2008., A live Web cast of ...
Cached Medicine News:Health News:ATS Medical Announces FDA Approval of the ATS 3f Aortic Bioprosthesis 2Health News:ATS Medical Announces FDA Approval of the ATS 3f Aortic Bioprosthesis 3Health News:ATS Medical Announces FDA Approval of the ATS 3f Aortic Bioprosthesis 4Health News:The Physical Therapy Profession Remains in High Demand 2Health News:The Physical Therapy Profession Remains in High Demand 3Health News:Video: Diabetes Ten City Challenge Celebrates Three Years of Success: 2Health News:Video: Diabetes Ten City Challenge Celebrates Three Years of Success: 3Health News:Video: Diabetes Ten City Challenge Celebrates Three Years of Success: 4Health News:Bayer Diabetes Care Names 'Walk In Nick's Shoes' (W.I.N.S.) Sweepstakes Grand Prize Winners 2Health News:Bayer Diabetes Care Names 'Walk In Nick's Shoes' (W.I.N.S.) Sweepstakes Grand Prize Winners 3Health News:Symmetry Medical to Report Third Quarter 2008 Financial Results on November 12, 2008 2
The Small External Fixator has straight or angled frames, independent pin placement, and combines easily with Large and Medium External Fixator frames....
The Medium External Fixator has a medium Combination Clamp that connects rod to rod or pin to rod as well as a Medium Multi-Pin Clamp that connects pins to rods allowing parallel pin placement....
... Holding Clamps have a slender design contributes ... tensioning of Kirschner wires. The Connecting Clamp ... Rods and/or Connecting Bar. Uses 3.0 mm ... Kirschner wires eliminate need to predrill and ...
... the DJD® II are to allow active or ... the articular surfaces of the elbow and collateral ... is designed to replicate the elbow's axis of ... articular surfaces from damaging each other. The DJD® ...
Medicine Products: